Medicinova Inc SEC filings MNOV
Medicinova Inc has 879 filings in SEC EDGAR's recent list, going back to Apr 8, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 19, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Mar 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 19, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 13, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 13, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 13, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 14, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 25, 2016 | Dec 31, 2015 |
| ARS | Annual report to shareholders | May 5, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 12, 2015 | Dec 31, 2014 |
| ARS | Annual report to shareholders | May 2, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 27, 2014 | Dec 31, 2013 |
| ARS | Annual report to shareholders | May 3, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 28, 2013 | Dec 31, 2012 |
| ARS | Annual report to shareholders | May 3, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 29, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 31, 2011 | Dec 31, 2010 |
| ARS | Annual report to shareholders | May 6, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Mar 24, 2010 | Dec 31, 2009 |
| ARS | Annual report to shareholders | May 4, 2009 | Dec 31, 2008 |
| 10-K | Annual report | Mar 31, 2009 | Dec 31, 2008 |
| ARS | Annual report to shareholders | May 8, 2008 | Dec 31, 2007 |
| 10-K | Annual report | Mar 17, 2008 | Dec 31, 2007 |
| ARS | Annual report to shareholders | Mar 14, 2007 | Dec 31, 2006 |
| 10-K | Annual report | Feb 15, 2007 | Dec 31, 2006 |
| 10-K | Annual report | Feb 16, 2006 | Dec 31, 2005 |
| ARS | Annual report to shareholders | Jun 28, 2005 | Dec 31, 2004 |
| 10-K | Annual report | Mar 22, 2005 | Dec 31, 2004 |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1226616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.